BROOKSPharmaceuticals
Brooks Laboratories Ltd — Profit & Loss Statement
₹37.11
-7.63%
Brooks Laboratories Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.10 Cr | 0.09 Cr | — |
| Tax Rate For Calcs | 0.30 | 0.30 | 0.19 | 0.19 | — |
| Normalized EBITDA | -7.16 Cr | -16.95 Cr | -29.90 Cr | -14.17 Cr | — |
| Total Unusual Items | 0.00 | 0.00 | 0.51 Cr | 0.45 Cr | — |
| Total Unusual Items Excluding Goodwill | 0.00 | 0.00 | 0.51 Cr | 0.45 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | -9.97 Cr | -19.59 Cr | -20.89 Cr | -19.31 Cr | — |
| Reconciled Depreciation | 1.60 Cr | 1.77 Cr | 7.03 Cr | 7.35 Cr | — |
| Reconciled Cost Of Revenue | 54.07 Cr | 56.62 Cr | 61.22 Cr | 75.80 Cr | — |
| EBITDA | -7.16 Cr | -16.95 Cr | -29.39 Cr | -13.72 Cr | — |
| EBIT | -8.76 Cr | -18.72 Cr | -36.42 Cr | -21.07 Cr | — |
| Net Interest Income | -1.03 Cr | -0.84 Cr | -2.09 Cr | -3.01 Cr | — |
| Interest Expense | 1.03 Cr | 0.84 Cr | 1.95 Cr | 2.83 Cr | — |
| Normalized Income | -9.97 Cr | -19.59 Cr | -21.31 Cr | -19.68 Cr | — |
| Net Income From Continuing And Discontinued Operation | -9.97 Cr | -19.59 Cr | -20.89 Cr | -19.31 Cr | — |
| Total Expenses | 79.22 Cr | 78.00 Cr | 96.03 Cr | 111.80 Cr | — |
| Diluted Average Shares | 2.68 Cr | 2.55 Cr | 2.47 Cr | 2.52 Cr | — |
| Basic Average Shares | 2.68 Cr | 2.55 Cr | 2.47 Cr | 2.52 Cr | — |
| Diluted EPS | -3.72 | -7.67 | -12.57 | -7.67 | — |
| Basic EPS | -3.72 | -7.67 | -12.57 | -7.67 | — |
| Diluted NI Availto Com Stockholders | -9.97 Cr | -19.59 Cr | -20.89 Cr | -19.31 Cr | — |
| Net Income Common Stockholders | -9.97 Cr | -19.59 Cr | -20.89 Cr | -19.31 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | -9.97 Cr | -19.59 Cr | -20.89 Cr | -19.31 Cr | — |
| Minority Interests | 0.00 | 0.00 | 10.15 Cr | 8.02 Cr | — |
| Net Income Including Noncontrolling Interests | -9.97 Cr | -19.59 Cr | -31.05 Cr | -19.31 Cr | — |
| Net Income Continuous Operations | -9.97 Cr | -19.59 Cr | -31.05 Cr | -19.31 Cr | — |
| Tax Provision | 0.18 Cr | 0.03 Cr | -7.32 Cr | -4.59 Cr | — |
| Pretax Income | -9.79 Cr | -19.57 Cr | -38.37 Cr | -23.90 Cr | — |
| Other Non Operating Income Expenses | 0.88 Cr | 0.92 Cr | 0.11 Cr | 0.14 Cr | — |
| Special Income Charges | 0.00 | 0.00 | 0.50 Cr | 0.45 Cr | — |
| Net Non Operating Interest Income Expense | -1.03 Cr | -0.84 Cr | -2.09 Cr | -3.01 Cr | — |
| Interest Expense Non Operating | 1.03 Cr | 0.84 Cr | 1.95 Cr | 2.83 Cr | — |
| Operating Income | 3.34 Cr | 1.48 Cr | -33.55 Cr | -21.70 Cr | — |
| Operating Expense | 25.15 Cr | 21.39 Cr | 34.81 Cr | 36.00 Cr | — |
| Other Operating Expenses | 10.58 Cr | 9.07 Cr | 0.39 Cr | 1.08 Cr | — |
| Depreciation And Amortization In Income Statement | 1.60 Cr | 1.77 Cr | 7.03 Cr | 7.35 Cr | — |
| Depreciation Income Statement | 1.60 Cr | 1.77 Cr | 7.03 Cr | 7.35 Cr | — |
| Gross Profit | 28.48 Cr | 22.87 Cr | 1.26 Cr | 14.29 Cr | — |
| Cost Of Revenue | 54.07 Cr | 56.62 Cr | 61.22 Cr | 75.80 Cr | — |
| Total Revenue | 82.56 Cr | 79.49 Cr | 62.48 Cr | 90.09 Cr | — |
| Operating Revenue | 82.56 Cr | 79.49 Cr | 62.48 Cr | 90.09 Cr | — |
| Interest Income | — | 0.07 Cr | 0.09 Cr | 0.09 Cr | 0.17 Cr |
| Rent Expense Supplemental | — | 90000.00 | 90000.00 | 0.30 Cr | 0.02 Cr |
| Write Off | — | 0.00 | 0.19 Cr | -0.22 Cr | 0.00 |
| Total Other Finance Cost | — | 0.12 Cr | 0.23 Cr | 0.27 Cr | — |
| Interest Income Non Operating | — | 0.07 Cr | 0.09 Cr | 0.09 Cr | 0.17 Cr |
| Amortization | — | 0.15 Cr | — | — | — |
| Selling General And Administration | — | 4.62 Cr | 10.43 Cr | 9.10 Cr | 6.81 Cr |
| Selling And Marketing Expense | — | 0.24 Cr | 0.34 Cr | 0.26 Cr | 0.26 Cr |
| General And Administrative Expense | — | 4.37 Cr | 10.09 Cr | 8.84 Cr | 6.55 Cr |
| Rent And Landing Fees | — | 90000.00 | 90000.00 | 0.30 Cr | 0.02 Cr |
| Other Special Charges | — | — | -0.70 Cr | -0.23 Cr | 0.02 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Brooks Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.